Tuesday, June 29, 2021 3:38:07 PM
Just thinking.
For the last 12 months CYDY has been a constant battle between longs and shorts. Shorts will do, say, and write anything as the fake research report and Culper, the firm in the short and distort lawsuit prove.
Why is this the case??
Because many longs see the medical gains that they will have available and the rest of the world eventually might use AND there is a huge profit potential.
What's in it for shorts? Best explanation is that to short 100 shares of CYDY at 1.70$ they must deposit with their broker 500$, borrow the shares, and then short those shares. They cant vote. They don't own anything. The buyer of that short can vote.
What? How is that? Well, its best explained as a market flaw. Joe Blow from Miami owns 100 shares at XZY Broker. XYZ for a handsome fee, loan the shares to Out of Your Mind NBroker and their customer; Shifty Investor shorts them, meaning he sold the borrowed shares/ Sally Bright bought the shorted shares. Sally can vote in the proxy as will Joe Blow. Shifty, the short seller never can vote.
If CYDY decrease 70Cents to 1$; Shifty makes 70 cents on his 5$ investment.
Any of the following can cause a 5$ to 10$ run in CYDY. Buy Out , Fantastic Long Hauler Trial, Brazil, Philippines, or India.
1.70$ to infinity as Buzz Lightyear would say. The longs can make a fortune. The shorts only 1.70$
For the last 12 months CYDY has been a constant battle between longs and shorts. Shorts will do, say, and write anything as the fake research report and Culper, the firm in the short and distort lawsuit prove.
Why is this the case??
Because many longs see the medical gains that they will have available and the rest of the world eventually might use AND there is a huge profit potential.
What's in it for shorts? Best explanation is that to short 100 shares of CYDY at 1.70$ they must deposit with their broker 500$, borrow the shares, and then short those shares. They cant vote. They don't own anything. The buyer of that short can vote.
What? How is that? Well, its best explained as a market flaw. Joe Blow from Miami owns 100 shares at XZY Broker. XYZ for a handsome fee, loan the shares to Out of Your Mind NBroker and their customer; Shifty Investor shorts them, meaning he sold the borrowed shares/ Sally Bright bought the shorted shares. Sally can vote in the proxy as will Joe Blow. Shifty, the short seller never can vote.
If CYDY decrease 70Cents to 1$; Shifty makes 70 cents on his 5$ investment.
Any of the following can cause a 5$ to 10$ run in CYDY. Buy Out , Fantastic Long Hauler Trial, Brazil, Philippines, or India.
1.70$ to infinity as Buzz Lightyear would say. The longs can make a fortune. The shorts only 1.70$
Recent CYDY News
- CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study • GlobeNewswire Inc. • 04/21/2026 08:10:00 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/20/2026 12:30:00 PM
- CytoDyn to Present at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/08/2026 09:15:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/08/2026 12:30:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 01:35:02 PM
- CytoDyn Closes $17.5 Million Financing to Fund Continued Development of Leronlimab • GlobeNewswire Inc. • 03/05/2026 01:30:00 PM
- CytoDyn Presents Novel CCR5 Inhibition Mechanisms and Long-Term Survival Signals for Leronlimab in Metastatic Breast Cancer at AACR Immuno-Oncology Conference • GlobeNewswire Inc. • 02/20/2026 01:30:00 PM
- CytoDyn Announces Funding and Initiation of Expanded Access Program for Patients with Triple-negative Breast Cancer • GlobeNewswire Inc. • 01/27/2026 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/09/2026 10:15:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/09/2026 01:30:45 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/22/2025 10:15:23 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/17/2025 05:15:14 AM
- December 2025 Letter to Shareholders • GlobeNewswire Inc. • 12/16/2025 01:30:00 PM
